Skip to main content
SpringerLink
Log in

Immunotherapy for Colon Cancer: Recent Perspectives

  • Chapter
  • First Online:
Theranostics Approaches to Gastric and Colon Cancer

Part of the book series: Diagnostics and Therapeutic Advances in GI Malignancies ((DTAGIM))

  • 397 Accesses

Abstract

Colorectal cancer (CRC) is third in cancer-related deaths among male and female populations. It is a slowly progressing malignancy and therefore, early detection of ulcers or the non-malignant polyps can prevent the disease and result in better patient outcomes. There are several treatment regimens, including chemotherapy and radiation that have been used for decades in treating CRC. Morbidity caused by intensive therapy and limitations in treatment due to late stage diagnoses impact the survival of CRC patients and dampen the quality of life of surviving patients. Alternative approaches such as immunotherapy have been tested for some time to address the issues associated with intensive chemotherapy. Several strategies that have been studied in pre-clinical models for CRC are recently gaining attention due to promising results, leading to clinical trials. Strategies including the use of monoclonal antibodies, vaccines, T cell stimulators, and immune checkpoint inhibitors are currently in clinical trials. The results of these clinical trials are crucial for immunotherapy usage as a part of standard care. Less toxic and more specific immunotherapeutic approaches are urgently required to address the morbidity of CRC patients, these approaches have the ability to reduce metastasis and increase the survival rate in CRC patients.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Altman V, Mann N (1948) Metastisizing carcinoid tumor of the appendix and cecum. Am J Surg 76(4):434–439

    Article  CAS  PubMed  Google Scholar 

  • Anderson AS et al (2019) Lifestyle in patients at increased risk of colorectal cancer. J Hum Nutr Diet 32(5):570–577

    Article  CAS  PubMed  Google Scholar 

  • Antelo M et al (2019) Lynch-like syndrome is as frequent as Lynch syndrome in early-onset nonfamilial nonpolyposis colorectal cancer. Int J Cancer 145(3):705–713

    Article  CAS  PubMed  Google Scholar 

  • Arnold M et al (2017) Global patterns and trends in colorectal cancer incidence and mortality. Gut 66(4):683–691

    Article  PubMed  Google Scholar 

  • Arora N, Gupta A, Singh PP (2017) Biological agents in gastrointestinal cancers: adverse effects and their management. J Gastrointest Oncol 8(3):485–498

    Article  PubMed  PubMed Central  Google Scholar 

  • Bat L et al (1992) Colonoscopy in patients aged 80 years or older and its contribution to the evaluation of rectal bleeding. Postgrad Med J 68(799):355–358

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Blackledge G et al (1979) A study of gastro-intestinal lymphoma. Clin Oncol 5(3):209–219

    CAS  PubMed  Google Scholar 

  • Bond JH (2002) Fecal occult blood test screening for colorectal cancer. Gastrointest Endosc Clin N Am 12(1):11–21

    Article  PubMed  Google Scholar 

  • Carethers JM, Stoffel EM (2015) Lynch syndrome and Lynch syndrome mimics: the growing complex landscape of hereditary colon cancer. World J Gastroenterol 21(31):9253–9261

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Carroll MR, Seaman HE, Halloran SP (2014) Tests and investigations for colorectal cancer screening. Clin Biochem 47(10–11):921–939

    Article  CAS  PubMed  Google Scholar 

  • Carvalho S et al (2016) Immunotherapy of cancer: from monoclonal to oligoclonal cocktails of anti-cancer antibodies: IUPHAR review 18. Br J Pharmacol 173(9):1407–1424

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Celluzzi CM et al (1996) Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity. J Exp Med 183(1):283–287

    Article  CAS  PubMed  Google Scholar 

  • Cherradi S et al (2017) Antibody targeting of claudin-1 as a potential colorectal cancer therapy. J Exp Clin Cancer Res 36(1):89

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cohen SA, Pritchard CC, Jarvik GP (2019) Lynch syndrome: from screening to diagnosis to treatment in the era of modern molecular oncology. Annu Rev Genomics Hum Genet 20:293–307

    Article  CAS  PubMed  Google Scholar 

  • Contreary K, Nance FC, Becker WF (1980) Primary lymphoma of the gastrointestinal tract. Ann Surg 191(5):593–598

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Corraliza-Gorjon I et al (2017) New strategies using antibody combinations to increase cancer treatment effectiveness. Front Immunol 8:1804

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • d’Amore F et al (1994) Non-Hodgkin’s lymphoma of the gastrointestinal tract: a population-based analysis of incidence, geographic distribution, clinicopathologic presentation features, and prognosis. Danish lymphoma study group. J Clin Oncol 12(8):1673–1684

    Article  PubMed  Google Scholar 

  • DeRycke MS et al (2017) Targeted sequencing of 36 known or putative colorectal cancer susceptibility genes. Mol Genet Genomic Med 5(5):553–569

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Deveney KE, Way LW (1984) Follow-up of patients with colorectal cancer. Am J Surg 148(6):717–722

    Article  CAS  PubMed  Google Scholar 

  • Di Franco S et al (2017) Role of type I and II interferons in colorectal cancer and melanoma. Front Immunol 8:878

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Eastman ME et al (2001) Central venous device-related infection and thrombosis in patients treated with moderate dose continuous-infusion interleukin-2. Cancer 91(4):806–814

    Article  CAS  PubMed  Google Scholar 

  • El-Menyar A, Mekkodathil A, Al-Thani H (2017) Diagnosis and management of gastrointestinal stromal tumors: an up-to-date literature review. J Cancer Res Ther 13(6):889–900

    CAS  PubMed  Google Scholar 

  • Force USPST (2008) Screening for colorectal cancer: U.S. preventive services task force recommendation statement. Ann Intern Med 149(9):627–637

    Article  Google Scholar 

  • Force USPST et al (2016) Screening for colorectal cancer: US preventive services task force recommendation statement. JAMA 315(23):2564–2575

    Article  CAS  Google Scholar 

  • Gothlin JH (1988) Modern radiological diagnostics in colorectal cancer. Scand J Gastroenterol Suppl 149:59–61

    Article  CAS  PubMed  Google Scholar 

  • Harada S, Morlote D (2020) Molecular pathology of colorectal cancer. Adv Anat Pathol 7(1):20–26

    Google Scholar 

  • Henry CA, Berry RE (1988) Primary lymphoma of the large intestine. Am Surg 54(5):262–266

    CAS  PubMed  Google Scholar 

  • Herrmann R et al (1980) Gastrointestinal involvement in non-Hodgkin’s lymphoma. Cancer 46(1):215–222

    Article  CAS  PubMed  Google Scholar 

  • Ilgenfritz HC, Mathews WR (1955) Carcinoid tumors of the gastro-intestinal tract. Ann Surg 141(6):807–818

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Issa IA, Noureddine M (2017) Colorectal cancer screening: an updated review of the available options. World J Gastroenterol 23(28):5086–5096

    Article  PubMed  PubMed Central  Google Scholar 

  • Kalyan A et al (2018) Updates on immunotherapy for colorectal cancer. J Gastrointest Oncol 9(1):160–169

    Article  PubMed  PubMed Central  Google Scholar 

  • Kim US, Papatestas AE, Aufses AH Jr (1976) Prognostic significance of peripheral lymphocyte counts and carcinoembryonic antigens in colorectal carcinoma. J Surg Oncol 8(3):257–262

    Article  CAS  PubMed  Google Scholar 

  • Klebanoff CA et al (2011) Therapeutic cancer vaccines: are we there yet? Immunol Rev 239(1):27–44

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Koch P et al (2001) Primary gastrointestinal non-Hodgkin’s lymphoma: I. anatomic and histologic distribution, clinical features, and survival data of 371 patients registered in the German multicenter study GIT NHL 01/92. J Clin Oncol 19(18):3861–3873

    Article  CAS  PubMed  Google Scholar 

  • Koelzer VH, Zlobec I, Lugli A (2016) Tumor budding in colorectal cancer–ready for diagnostic practice? Hum Pathol 47(1):4–19

    Article  PubMed  Google Scholar 

  • Koido S et al (2000) Induction of antitumor immunity by vaccination of dendritic cells transfected with MUC1 RNA. J Immunol 165(10):5713–5719

    Article  CAS  PubMed  Google Scholar 

  • Lee DH, Lee JM (2017) Whole-body PET/MRI for colorectal cancer staging: is it the way forward? J Magn Reson Imaging 45(1):21–35

    Article  PubMed  Google Scholar 

  • Lee HS et al (2017) Molecular testing for gastrointestinal cancer. J Pathol Transl Med 51(2):103–121

    Article  PubMed  PubMed Central  Google Scholar 

  • Levin B et al (2008a) Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US multi-society task force on colorectal cancer, and the American College of Radiology. CA Cancer J Clin 58(3):130–160

    Article  PubMed  Google Scholar 

  • Levin B et al (2008b) Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US multi-society task force on colorectal cancer, and the American College of Radiology. Gastroenterology 134(5):1570–1595

    Article  CAS  PubMed  Google Scholar 

  • Li J et al (2016) Point mutations in exon 1B of APC reveal gastric adenocarcinoma and proximal polyposis of the stomach as a familial adenomatous polyposis variant. Am J Hum Genet 98(5):830–842

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Liu B et al (1996) Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients. Nat Med 2(2):169–174

    Article  CAS  PubMed  Google Scholar 

  • Lohmueller J, Finn OJ (2017) Current modalities in cancer immunotherapy: Immunomodulatory antibodies, CARs and vaccines. Pharmacol Ther 178:31–47

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lugli A et al (2017) Recommendations for reporting tumor budding in colorectal cancer based on the international tumor budding consensus conference (ITBCC) 2016. Mod Pathol 30(9):1299–1311

    Article  PubMed  Google Scholar 

  • Lynch HT, Smyrk T (1996) Hereditary nonpolyposis colorectal cancer (Lynch syndrome). An updated review. Cancer 78(6):1149–1167

    Article  CAS  PubMed  Google Scholar 

  • Lynch HT et al (1990a) Phenotypic variation in colorectal adenoma/cancer expression in two families. Hereditary flat adenoma syndrome. Cancer 66(5):909–915

    Article  CAS  PubMed  Google Scholar 

  • Lynch HT et al (1990b) Genetic diagnosis of Lynch syndrome II in an extended colorectal cancer-prone family. Cancer 66(10):2233–2238

    Article  CAS  PubMed  Google Scholar 

  • Machi J et al (1987) Intraoperative ultrasonography in screening for liver metastases from colorectal cancer: comparative accuracy with traditional procedures. Surgery 101(6):678–684

    CAS  PubMed  Google Scholar 

  • Mahar AL et al (2017) Personalizing prognosis in colorectal cancer: a systematic review of the quality and nature of clinical prognostic tools for survival outcomes. J Surg Oncol 116(8):969–982

    Article  PubMed  PubMed Central  Google Scholar 

  • Maher SG et al (2008) IFNalpha and IFNlambda differ in their antiproliferative effects and duration of JAK/STAT signaling activity. Cancer Biol Ther 7(7):1109–1115

    Article  CAS  PubMed  Google Scholar 

  • Marur S et al (2010) HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol 11(8):781–789

    Article  PubMed  PubMed Central  Google Scholar 

  • Matsui O et al (1987) Liver metastases from colorectal cancers: detection with CT during arterial portography. Radiology 165(1):65–69

    Article  CAS  PubMed  Google Scholar 

  • Mazzola P et al (2008) Epidemiology and molecular biology of gastrointestinal stromal tumors (GISTs): a population-based study in the south of Switzerland, 1999-2005. Histol Histopathol 23(11):1379–1386

    PubMed  Google Scholar 

  • McCloskey CW et al (2018) Ovarian cancer immunotherapy: preclinical models and emerging therapeutics. Cancers (Basel) 10(8):244

    Article  CAS  Google Scholar 

  • Min KW, Leabu M (2006) Interstitial cells of Cajal (ICC) and gastrointestinal stromal tumor (GIST): facts, speculations, and myths. J Cell Mol Med 10(4):995–1013

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Mosolits S, Nilsson B, Mellstedt H (2005) Towards therapeutic vaccines for colorectal carcinoma: a review of clinical trials. Expert Rev Vaccines 4(3):329–350

    Article  CAS  PubMed  Google Scholar 

  • Muto T, Bussey HJ, Morson BC (1975) The evolution of cancer of the colon and rectum. Cancer 36(6):2251–2270

    Article  CAS  PubMed  Google Scholar 

  • Myers G (2018) Immune-related adverse events of immune checkpoint inhibitors: a brief review. Curr Oncol 25(5):342–347

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Nasseri Y, Langenfeld SJ (2017) Imaging for colorectal cancer. Surg Clin North Am 97(3):503–513

    Article  PubMed  Google Scholar 

  • Nestle FO et al (1998) Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nat Med 4(3):328–332

    Article  CAS  PubMed  Google Scholar 

  • Northover JM, Murday V (1989) Familial colorectal cancer and familial adenomatous polyposis. Baillieres Clin Gastroenterol 3(3):593–613

    Article  CAS  PubMed  Google Scholar 

  • Palmer KJ et al (2000) Interferon-alpha (IFN-alpha) stimulates anti-melanoma cytotoxic T lymphocyte (CTL) generation in mixed lymphocyte tumour cultures (MLTC). Clin Exp Immunol 119(3):412–418

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Perica K et al (2015) Adoptive T cell immunotherapy for cancer. Rambam Maimonides Med J 6(1):e0004

    Article  PubMed  PubMed Central  Google Scholar 

  • Potter JD, McMichael AJ (1986) Diet and cancer of the colon and rectum: a case-control study. J Natl Cancer Inst 76(4):557–569

    Article  CAS  PubMed  Google Scholar 

  • Prendergast GC et al (2018) Indoleamine 2,3-Dioxygenase and its therapeutic inhibition in cancer. Int Rev Cell Mol Biol 336:175–203

    Article  PubMed  Google Scholar 

  • Raut CP, Morgan JA, Ashley SW (2007) Current issues in gastrointestinal stromal tumors: incidence, molecular biology, and contemporary treatment of localized and advanced disease. Curr Opin Gastroenterol 23(2):149–158

    Article  PubMed  Google Scholar 

  • Rossi M et al (2018) Colorectal cancer and alcohol consumption-populations to molecules. Cancers (Basel) 10(2):38

    Article  CAS  Google Scholar 

  • Schlag P et al (1992) Active specific immunotherapy with Newcastle-disease-virus-modified autologous tumor cells following resection of liver metastases in colorectal cancer. First evaluation of clinical response of a phase II-trial. Cancer Immunol Immunother 35(5):325–330

    Article  CAS  PubMed  Google Scholar 

  • Schulze T et al (2009) Efficiency of adjuvant active specific immunization with Newcastle disease virus modified tumor cells in colorectal cancer patients following resection of liver metastases: results of a prospective randomized trial. Cancer Immunol Immunother 58(1):61–69

    Article  CAS  PubMed  Google Scholar 

  • Sedykh SE et al (2018) Bispecific antibodies: design, therapy, perspectives. Drug Des Devel Ther 12:195–208

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Segnan N et al (2005) Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates. J Natl Cancer Inst 97(5):347–357

    Article  PubMed  Google Scholar 

  • Sepulveda AR et al (2017) Molecular biomarkers for the evaluation of colorectal cancer: guideline from the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and the American Society of Clinical Oncology. J Clin Oncol 35(13):1453–1486

    Article  CAS  PubMed  Google Scholar 

  • Shinya H, Wolff WI (1979) Morphology, anatomic distribution and cancer potential of colonic polyps. Ann Surg 190(6):679–683

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Siegel RL et al (2017) Colorectal cancer statistics, 2017. CA Cancer J Clin 67(3):177–193

    Article  PubMed  Google Scholar 

  • Siegel RL, Miller KD, Jemal A (2019) Cancer statistics, 2019. CA Cancer J Clin 69(1):7–34

    Article  PubMed  Google Scholar 

  • Singh PP et al (2015) Immune checkpoints and immunotherapy for colorectal cancer. Gastroenterol Rep (Oxf) 3(4):289–297

    Google Scholar 

  • Swerdlow SH et al (2016) The 2016 revision of the world health organization classification of lymphoid neoplasms. Blood 127(20):2375–2390

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Terme M et al (2013) VEGFA-VEGFR pathway blockade inhibits tumor-induced regulatory T-cell proliferation in colorectal cancer. Cancer Res 73(2):539–549

    Article  CAS  PubMed  Google Scholar 

  • Trombold J, Farmer RW, McCafferty M (2013) The impact of colorectal cancer screening in a veteran hospital population. Am Surg 79(3):296–300

    PubMed  Google Scholar 

  • Uyl-de Groot CA et al (2005) Immunotherapy with autologous tumor cell-BCG vaccine in patients with colon cancer: a prospective study of medical and economic benefits. Vaccine 23(17–18):2379–2387

    Article  CAS  PubMed  Google Scholar 

  • Valle L et al (2019) Genetic predisposition to colorectal cancer: syndromes, genes, classification of genetic variants and implications for precision medicine. J Pathol 247(5):574–588

    Article  PubMed  PubMed Central  Google Scholar 

  • Vermorken JB et al (1999) Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial. Lancet 353(9150):345–350

    Article  CAS  PubMed  Google Scholar 

  • Weng YJ et al (1996) Carcinoid tumors of the gastrointestinal tract in Chinese of Taiwan: an analysis of fifty cases. Zhonghua Yi Xue Za Zhi (Taipei) 58(4):254–258

    CAS  Google Scholar 

  • Winawer SJ, Sherlock P (1976) Approach to screening and diagnosis in colorectal cancer. Semin Oncol 3(4):387–397

    CAS  PubMed  Google Scholar 

  • Wu X, Lin H, Li S (2019) Prognoses of different pathological subtypes of colorectal cancer at different stages: a population-based retrospective cohort study. BMC Gastroenterol 19(1):164

    Article  PubMed  PubMed Central  Google Scholar 

  • Yasunaga M et al (2019) Significant antitumor effect of an antibody against TMEM180, a new colorectal cancer-specific molecule. Cancer Sci 110(2):761–770

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Texas College of Osteopathic Medicine, UNT Health Science Center, Fort Worth, TX, USA

    Christoffer B. Lambring, Sohail Siraj, Krishna Patel & Riyaz Basha

  2. Old Dominion University, Norfolk, VA, USA

    Chloe Smith

Authors
  1. Christoffer B. Lambring
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Chloe Smith
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sohail Siraj
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Krishna Patel
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Riyaz Basha
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Riyaz Basha .

Editor information

Editors and Affiliations

  1. Department of Energy and Materials Engineering, Dongguk University-Seoul, Jung-gu, Seoul, Korea (Republic of)

    Ganji Seeta Rama Raju

  2. Guru Ghasidas University, Bilaspur, Chhattisgarh, India

    L.V.K.S. Bhaskar

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Lambring, C.B., Smith, C., Siraj, S., Patel, K., Basha, R. (2020). Immunotherapy for Colon Cancer: Recent Perspectives. In: Raju, G., Bhaskar, L. (eds) Theranostics Approaches to Gastric and Colon Cancer. Diagnostics and Therapeutic Advances in GI Malignancies. Springer, Singapore. https://doi.org/10.1007/978-981-15-2017-4_12

Download citation

Publish with us

Policies and ethics

Search

Navigation